Implants News and Research

RSS

Cardiac Concepts initiates enrollment in European trial of RespiCardia System for CSA

Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.

8 Jul 2010

Modern Plastics adds MediPEEK-IM products

Modern Plastics has added extruded-plate MediPEEK-IM, a permanent implantable medical-grade PEEK (Polyetheretherketone), to its medical-grade plastics offering. MediPEEK-IM is a high-performance semi-crystalline thermoplastic designed for long-term body contact. The resin is produced to ASTM F2026 specifications and has been extensively tested to ISO-10993 requirements.

7 Jul 2010

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter which is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). It is the first VCF to be developed that is bidirectional and thus permits insertion or retrieval from either the femoral or jugular veins.

7 Jul 2010

Amedica, SUNY Upstate Medical University partner in comparative study of biomaterials

Amedica Corporation, a spinal and orthopaedic implant and instrument manufacturer focused on unique silicon nitride (SiN) ceramic technologies, announced that it has entered into an agreement with SUNY Upstate Medical University to conduct an additional research study that evaluates the company's SiN ceramic technology compared to PEEK interbody fusion devices. The two-year study will measure the fusion performance of the two biomaterials.

2 Jul 2010

New device could improve conventional cochlear implants

More electrodes and a thinner, more flexible wire inserted further into the inner ear could improve conventional cochlear implants, a team of Medical College of Georgia and Georgia Institute of Technology researchers say.

2 Jul 2010

Researchers uncover potential drug treatment for noise-induced hearing loss

Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.

1 Jul 2010

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

Using advanced 3D/4D ultrasound to guide embryo transfer during in vitro fertilization (IVF) significantly reduces a woman's risk of ectopic pregnancy and its associated complications, Robert Gergely, M.D., medical director, 3D Sonography Center of Beverly Hills, reported today.

30 Jun 2010

AqueSys secures $35 million in Series C financing round

AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.

30 Jun 2010

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Biomet, Inc. announced today fourth quarter and fiscal year 2010 preliminary net sales results for the year ended May 31, 2010.

28 Jun 2010

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top choice to take to trial and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX. The first case to reach a verdict, Maley v. Merck, resulted in a defense verdict for Merck on May 5, 2010.

28 Jun 2010

Researchers say ear tubes are safe for children with cochlear implants

Children who are being treated for hearing loss with cochlear implants can safely have ear tubes installed to help clear up infections, say researchers at the University of Alabama at Birmingham (UAB).

25 Jun 2010

Tryton announces first three implants of Side Branch Stent System in Israel

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the company's TRYTON Side Branch Stent™ System has been used in three cases in Israel for the first time.

24 Jun 2010

IsoRay, Hologic complete exclusive worldwide distribution agreement for GliaSite radiation therapy system

IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.

From Hologic, Inc. 23 Jun 2010

Aesculap Implant Systems introduces S4 MIS Cannulated Pedicle Screw Spine Fusion System

Aesculap Implant Systems, LLC is pleased to announce the launch of the S4® MIS (Minimally Invasive Solutions) Cannulated Pedicle Screw Spine Fusion System.

22 Jun 2010

Investment report on ULURU

MicroStockProfit.com announces an investment report featuring ULURU Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Jun 2010

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

Medtronic, Inc. today announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate bone cement containing hydroxyapatite for use in the treatment of patients with vertebral compression fractures who are undergoing minimally invasive surgery with KYPHON Balloon Kyphoplasty.

22 Jun 2010

United American Healthcare acquires Pulse Systems

United American Healthcare Corporation today announced it has acquired privately held Pulse Systems, LLC. Based in Concord, Calif., Pulse Systems, LLC provides contract manufacturing services to the medical device industry, with a focus on precision laser-cutting capabilities and the processing of thin-wall tubular metal components, sub-assemblies and implants, primarily in the cardiovascular market. For the fiscal year ended Dec. 31, 2009, Pulse Systems generated revenue of approximately $9.2 million.

19 Jun 2010

One-step surgery positively impacts patient's quality of life: Study

Restoring people's health and returning them to their daily lives as soon as possible is the goal following any surgery. When a person's ability to eat and speak is affected, as with cancer in the mouth, surgery is particularly disruptive, creating a greater challenge. A one-step surgery can remove cancerous tissue and reconstruct bone and teeth functionality immediately, positively impacting the patient's quality of life.

18 Jun 2010

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received preliminary results for CLOSURE I, its patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

18 Jun 2010

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Arthroplasty outside the United States. The PyroTITAN was implanted last month in Brisbane, Australia in a 46-year-old patient who reported "immediate pain relief" within 24 hours of surgery. The PyroTITAN Humeral Resurfacing implant is the first commercially-available shoulder arthroplasty prosthesis made of PyroCarbon in the world.

17 Jun 2010

Implants News and Research

Cardiac Concepts initiates enrollment in European trial of RespiCardia System for CSA

Modern Plastics adds MediPEEK-IM products

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Amedica, SUNY Upstate Medical University partner in comparative study of biomaterials

New device could improve conventional cochlear implants

Researchers uncover potential drug treatment for noise-induced hearing loss

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

AqueSys secures $35 million in Series C financing round

Biomet fourth-quarter worldwide net sales up 10% to $703 million

Merck challenges New York jury decision in federal FOSAMAX retrial

Researchers say ear tubes are safe for children with cochlear implants

Tryton announces first three implants of Side Branch Stent System in Israel

IsoRay, Hologic complete exclusive worldwide distribution agreement for GliaSite radiation therapy system

Aesculap Implant Systems introduces S4 MIS Cannulated Pedicle Screw Spine Fusion System

Investment report on ULURU

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

United American Healthcare acquires Pulse Systems

One-step surgery positively impacts patient's quality of life: Study

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News